Guardant Health, Inc.
GH
$129.30
-$3.92-2.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 301.67M | 281.27M | 265.20M | 232.09M | 203.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 301.67M | 281.27M | 265.20M | 232.09M | 203.47M |
| Cost of Revenue | 104.92M | 99.49M | 93.59M | 81.21M | 74.72M |
| Gross Profit | 196.75M | 181.77M | 171.61M | 150.88M | 128.75M |
| SG&A Expenses | 227.06M | 204.20M | 180.53M | 169.62M | 150.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 423.02M | 401.96M | 364.07M | 338.27M | 314.02M |
| Operating Income | -121.35M | -120.69M | -98.87M | -106.18M | -110.55M |
| Income Before Tax | -111.70M | -130.22M | -92.59M | -99.86M | -94.87M |
| Income Tax Expenses | 372.00K | -1.73M | 136.00K | 38.00K | 290.00K |
| Earnings from Continuing Operations | -112.08M | -128.49M | -92.73M | -99.90M | -95.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -112.08M | -128.49M | -92.73M | -99.90M | -95.16M |
| EBIT | -121.35M | -120.69M | -98.87M | -106.18M | -110.55M |
| EBITDA | -111.91M | -110.64M | -89.47M | -96.14M | -100.32M |
| EPS Basic | -0.85 | -1.00 | -0.74 | -0.80 | -0.77 |
| Normalized Basic EPS | -0.53 | -0.57 | -0.46 | -0.50 | -0.52 |
| EPS Diluted | -0.85 | -1.00 | -0.74 | -0.80 | -0.77 |
| Normalized Diluted EPS | -0.53 | -0.57 | -0.46 | -0.50 | -0.52 |
| Average Basic Shares Outstanding | 131.27M | 128.66M | 124.81M | 124.11M | 123.87M |
| Average Diluted Shares Outstanding | 131.27M | 128.66M | 124.81M | 124.11M | 123.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |